Piper Sandler Remains a Buy on Edgewise Therapeutics (EWTX)

2 days ago · In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Edgewise Therapeutics (EWTX – Research Report), with a price target of $51.00. …

$51.00
OFF

Piper Sandler Remains A Buy On Edgewise Therapeutics (EWTX)

2 weeks from now

2 days ago · In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Edgewise Therapeutics (EWTX – Research Report), with a price target of $51.00. …

businessinsider.com

$48.00
OFF

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap Down

2 weeks from now

Jan 6, 2025 · Finally, Piper Sandler boosted their target price on Edgewise Therapeutics from $48.00 to $51.00 and gave the stock an "overweight" rating in a report on Friday, October …

marketbeat.com

$51.00
OFF

Edgewise Therapeutics Shares Maintain Price Target On Positive Data

2 weeks from now

Oct 30, 2024 · On Wednesday, Piper Sandler maintained its Overweight rating and $51.00 stock price target for Edgewise Therapeutics (NASDAQ:EWTX). The firm expressed continued …

investing.com

$48.00
OFF

Piper Sandler Maintains Target On Edgewise Therapeutics Stock

2 weeks from now

Aug 12, 2024 · Piper Sandler has maintained a confident stance on Edgewise Therapeutics (NASDAQ: EWTX), reiterating an Overweight rating with a $48.00 price target. The firm's …

investing.com

$38
OFF

Edgewise Therapeutics (NASDAQ:EWTX) Stock, Analyst Ratings, …

2 weeks from now

Edgewise Therapeutics Inc has a consensus price target of $38 based on the ratings of 8 analysts. The high is $51 issued by Piper Sandler on October 11, 2024.The low is $5 issued …

benzinga.com

03%
OFF

Piper Sandler Reiterates “Overweight” Rating For Edgewise …

2 weeks from now

Jul 1, 2024 · Piper Sandler’s price objective indicates a potential upside of 171.03% from the stock’s current price. A number of other […] Edgewise Therapeutics (NASDAQ:EWTX – Get …

etfdailynews.com

$48.00
OFF

Piper Sandler Raises Edgewise Therapeutics (NASDAQ:EWTX) Price …

2 weeks from now

Oct 13, 2024 · Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) had its target price upped by stock analysts at Piper Sandler from $48.00 to $51.00 in a report issued on Friday, …

americanbankingnews.com

50%
OFF

Edgewise Therapeutics Soars 50%: Key Reasons Behind The Surge

2 weeks from now

Edgewise Therapeutics (NASDAQ: EWTX) is up 50% in a single session and 450% from recent lows for a reason. ... That was set by Piper Sandler earlier this year and implies a 70% upside …

msn.com

5%
OFF

Edgewise Therapeutics (NASDAQ:EWTX) Shares Up 4.5

2 weeks from now

Oct 11, 2024 · Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) shares shot up 4.5% during mid-day trading on Friday after Piper Sandler raised their price target on the stock …

marketbeat.com

$48.00
OFF

Piper Sandler Reiterates Overweight Rating On Edgewise …

2 weeks from now

Jul 1, 2024 · Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $48.00 price target on Edgewise Therapeutics (NASDAQ: EWTX).The analyst commented, "We …

streetinsider.com

$51.00
OFF

Truist Financial Remains A Buy On Edgewise Therapeutics (EWTX)

2 weeks from now

2 days ago · In a report released today, Piper Sandler also maintained a Buy rating on the stock with a $51.00 price target. See Insiders’ Hot Stocks on TipRanks >> EWTX market cap is …

businessinsider.com

FAQs about Piper Sandler Remains a Buy on Edgewise Therapeutics (EWTX) Coupon?

Is Piper Sandler (ewtx) a good stock to buy?

In a report released today, Piper Sandler also maintained a Buy rating on the stock with a $51.00 price target. EWTX market cap is currently $2.29B and has a P/E ratio of -16.98. Based on the recent corporate insider activity of 29 insiders, corporate insider sentiment is negative on the stock. ...

Is Edgewise Therapeutics a good stock to buy?

Edgewise Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $51.75, which is a 104.30% upside from current levels. In a report released today, Piper Sandler also maintained a Buy rating on the stock with a $51.00 price target. ...

Will Piper Sandler's healthcare stock have a 70% upside?

That was set by Piper Sandler earlier this year and implies a 70% upside is possible for this healthcare stock within the next twelve months. Institutional activity is also bullish for this market. The institutional activity is robustly in favor of higher prices, surging to a record in Q2 and sustaining a solid pace in Q3. ...

Will Edgewise therapeutics be a catalyst for the muscular dystrophy market?

Edgewise Therapeutics has an attractive, if small, pipeline of candidates in early stage 1 and stage 2 trials. They target individuals with Duchenne and Becker muscular dystrophy and have shown positive results to date. The next batch of results from these tests is expected in Q4 of this year and may provide another catalyst for the market. ...

Is ewtx a good stock to buy?

The company has over half a billion in cash, sufficient to sustain operations at recent levels for over 15 quarters. The price chart of EWTX looks good. The market is recovering from its post-IPO blahs and appears to be in a full reversal. ...